- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02730559
Motivational Interviewing With Dyslipidemic Adolescents Together With a Parent Versus With Adolescents Alone: A Mixed Methods Clinical Trial
April 5, 2016 updated by: Brian McCrindle, The Hospital for Sick Children
The primary focus of this proposal is to address growing concern of overweight/ obese adolescents with hyperlipidemia.
The proposed study is a 2-arm randomized controlled clinical trial to compare the effectiveness of Motivational interviewing (MI) interventions with the parent and adolescent dyad versus adolescent (10-17yr) alone.
The patients will be recruited from the Lipid clinic at Sick Kids.
The study hypothesis is that parent child dyad will have more success due to the possible synergetic effect compared to adolescents alone.
The study's primary outcome is cholesterol levels (Triglycerides/HDL ratio) and secondary outcomes include overall improvement in their lifestyle and their responses to the MI intervention.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
32
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
10 years to 17 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age at randomization: 10-17 years old
- 12 hour fasting lipid profile with triglycerides ≥39 mg/dL (1.0 mmol/L) or HDL-C ≤46 mg/dL (1.2 mmol/L), and with non-HDL-C ≥123 mg/dL (3.2 mmol/L)
- Waist to height ratio ≥0.5.
Exclusion Criteria:
- On lipid lowering medication
- non-English speaking
- Developmentally delayed
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention Group
Group A (Parent-adolescent dyads)
|
Motivational Interviewing/Counselling
|
|
Active Comparator: Control Group - Active Comparator
Group B (Adolescents only)
|
Motivational Interviewing/Counselling
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Changes in total cholesterol to HDL-C ratio
Time Frame: Initial clinic visit (baseline); Repeated 6 months after baseline;
|
Initial clinic visit (baseline); Repeated 6 months after baseline;
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2012
Primary Completion (Actual)
June 1, 2014
Study Registration Dates
First Submitted
March 31, 2016
First Submitted That Met QC Criteria
April 5, 2016
First Posted (Estimate)
April 6, 2016
Study Record Updates
Last Update Posted (Estimate)
April 6, 2016
Last Update Submitted That Met QC Criteria
April 5, 2016
Last Verified
April 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1000035605
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dyslipidemias
-
IlDong Pharmaceutical Co LtdCompletedMixed DyslipidemiasKorea, Republic of
-
Orient Pharma Co., Ltd.CompletedPrimary Hypercholesterolemia | Mixed DyslipidemiasTaiwan, Australia, New Zealand
-
Bisirna Therapeutics (Suzhou) Co., Ltd.Not yet recruiting
-
Université de SherbrookeRecruiting
-
Shandong Suncadia Medicine Co., Ltd.Not yet recruiting
-
Daewoong Pharmaceutical Co. LTD.Not yet recruiting
-
U.G.A. NutraceuticalsNot yet recruiting
-
Shandong Suncadia Medicine Co., Ltd.RecruitingHyperlipidemiasChina
-
NUR International UniversityCompletedDyslipidaemiaPakistan
-
Riphah International UniversityCompleted
Clinical Trials on Motivational Interviewing/Counselling
-
Western University, CanadaRecruitingHead and Neck Cancer | SurvivorshipCanada
-
University of StellenboschColumbia University; McMaster UniversityActive, not recruitingHIV Infections | Breastfeeding, ExclusiveSouth Africa
-
University of Maryland, BaltimoreMaryland Department of Health and Mental HygieneCompletedFractures, Bone | Smoking, TobaccoUnited States
-
Johns Hopkins UniversityZanvyl and Isabelle Krieger FundCompleted
-
Massachusetts General HospitalCompletedACS - Acute Coronary SyndromeUnited States
-
Washington University School of MedicineNational Institute of Mental Health (NIMH)Completed
-
Qazvin University Of Medical SciencesCompletedObesity, AdolescentIran, Islamic Republic of
-
Veterans Medical Research FoundationThe Tug McGraw FoundationCompleted
-
University of MichiganNational Heart, Lung, and Blood Institute (NHLBI); University of Iowa; American... and other collaboratorsCompletedChildhood ObesityUnited States
-
University of StellenboschUniversity of British Columbia; McMaster UniversityCompletedText Messaging Plus Motivational Interviewing in Promotion of Breastfeeding Among HIV-infected WomenHIV Infections | Breast FeedingSouth Africa